Insider · CIK 0002111400
Milano Furuta
Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing -, latest -.
In brief
Milano Furuta files SEC Form 4 as CFO and director at TAK (TAKEDA PHARMACEUTICAL CO LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Milano Furuta has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Ordinary Shares | +12,300 | $0.00 | $0 | 70,200 | Jul 6, 2026 |
| Jul 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | DDisposition to issuer Tax Obligation Awardderivative | -16,619 | $4,931.50 | $82M | 0 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +4,288 | $0.00 | $0 | 11,741 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +4,288 | $0.00 | $0 | 8,482 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +4,288 | $0.00 | $0 | 4,288 | Jul 6, 2026 |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Ordinary Shares | +7,800 | $0.00 | $0 | 57,900 | Apr 28, 2026 |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +7,814 | $0.00 | $0 | 16,619 | Apr 28, 2026 |
Questions about Milano Furuta
Answered from the filings on this page, as of the latest one.
Is Milano Furuta buying or selling?
Milano Furuta has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Milano Furuta's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Milano Furuta has 0.
Where does Milano Furuta file Form 4?
Milano Furuta has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.